Vault-13

MONOPAR THERAPEUTICS INC MNPR

COM · Common Stock · CUSIP 61023L108

9 institutional holders -3 vs Q1 2023
192,440192.4k shares reported held*
$164.5kreported value*
2 new 2 added 1 reduced 5 sold out net sold ≈ $33.3k (-39.2k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.85.

Trends to Q2 2023

Institutional holders

Managers reporting a position, each quarter

051015Q3 22: 11Q4 22: 11Q1 23: 12Q2 23: 99Q3 22Q4 22Q1 23Q2 23
Numbers
QuarterHolders
Q3 202211
Q4 202211
Q1 202312
Q2 20239

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q4 22: 5 bought or addedQ4 22: 5 cut or sold outQ4 22Q1 23: 5 bought or addedQ1 23: 3 cut or sold outQ1 23Q2 23: 4 bought or addedQ2 23: 6 cut or sold outQ2 23
Numbers
QuarterBought or addedCut or sold out
Q4 202255
Q1 202353
Q2 202346

Biggest buyers

MILLENNIUM MANAGEMENT LLC New +32,761+32.8k
Tower Research Capital LLC (TRC) Added +3,020+3.0k
FMR LLC New +150+150
WELLS FARGO & COMPANY/MN Added +2+2

Biggest sellers

NORTHERN TRUST CORP Sold out -37,051-37.1k
KESTRA PRIVATE WEALTH SERVICES, LLC Sold out -23,455-23.5k
UBS Group AG Sold out -6,388-6.4k
ROYAL BANK OF CANADA Sold out -5,000-5.0k
JPMORGAN CHASE & CO Sold out -2,414-2.4k
VANGUARD GROUP INC Reduced -800-800

Insider purchases and sales in Q2 2023

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q3 21: 0 buyingQ3 21: 0 sellingQ4 21: 0 buyingQ4 21: 0 sellingQ4 21Q1 22: 0 buyingQ1 22: 0 sellingQ2 22: 0 buyingQ2 22: 0 sellingQ2 22Q3 22: 0 buyingQ3 22: 0 sellingQ4 22: 1 buyingQ4 22: 0 sellingQ4 22Q1 23: 0 buyingQ1 23: 0 sellingQ2 23: 0 buyingQ2 23: 0 sellingQ2 23
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q3 20210—0——
Q4 20210—0——
Q1 20220—0——
Q2 20220—0——
Q3 20220—0——
Q4 20221$49.7k0——
Q1 20230—0——
Q2 20230—0——

None reported in Q2 2023.

Holders, Q2 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 99,17699.2k $84.8k $84.8k 0.00% Reduced -800 -800
2 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 41,89241.9k $35.8k $35.8k 0.00% Unchanged
3 MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio NEW YORK, NY 32,76132.8k $28.0k $28.0k 0.00% New
4 Rappaport Reiches Capital Management, LLC 0.00% of their portfolio SKOKIE`, IL 10,69510.7k $9.1k $9.1k 0.00% Unchanged
5 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 4,0004.0k $3.4k $3.4k 0.00% Unchanged
6 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 3,7333.7k $3.2k $3.2k 0.00% Added +3.0k +3,020
7 FMR LLC 0.00% of their portfolio BOSTON, MA 150150 $128 $128 0.00% New
8 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 3333 $28 $28 0.00% Added +2 +2
9 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged